Source:http://linkedlifedata.com/resource/pubmed/id/12900953
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2003-8-5
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1091-4269
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
51-2
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12900953-Adult,
pubmed-meshheading:12900953-Anxiety Disorders,
pubmed-meshheading:12900953-Female,
pubmed-meshheading:12900953-GABA Agonists,
pubmed-meshheading:12900953-Humans,
pubmed-meshheading:12900953-Male,
pubmed-meshheading:12900953-Middle Aged,
pubmed-meshheading:12900953-Neurotransmitter Uptake Inhibitors,
pubmed-meshheading:12900953-Nipecotic Acids,
pubmed-meshheading:12900953-Treatment Outcome
|
pubmed:year |
2003
|
pubmed:articleTitle |
Tiagabine for the treatment of anxiety.
|
pubmed:publicationType |
Letter,
Clinical Trial
|